Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 20 entities : Gilead sciences, inc. save search
Veru Announces Positive Updated Data from Phase 1b/2 Sabizabulin Study in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 ESMO Congress
Published: 2021-09-20 (Crawled : 13:15) - biospace.com/
VERU | $1.27 0.0% 2.6M
|
Health Technology
|
| O: -4.25%
H: 3.62%
C: -1.17%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.14%
H: 1.4%
C: 0.04%
prostate cancer phase 1 positive cancer phase 1b sabizabulin phase 2b
Aadi Bioscience Appoints Brendan Delaney as Chief Operating Officer
Published: 2021-09-20 (Crawled : 13:00) - biospace.com/
AADI | $1.845 -2.9% -2.98% 84K
|
Manufacturing
|
| O: -0.07%
H: 0.07%
C: -0.82%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: 0.16%
H: 3.69%
C: 2.54%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.14%
H: 1.4%
C: 0.04%
bioscience
Gilead to Present Latest Antiviral Research Data Addressing Urgent Global Needs in Infectious Disease at IDWeek 2021
Published: 2021-09-20 (Crawled : 13:00) - biospace.com/
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.14%
H: 1.4%
C: 0.04%
disease infectious disease test antiviral research
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.